Predictive value of dopamine transporter SPECT imaging with [123I]PE2I in patients with subtle parkinsonian symptoms
✍ Scribed by Morten Ziebell; Birgitte B. Andersen; Gerda Thomsen; Lars H. Pinborg; Merete Karlsborg; Steen G. Hasselbalch; Gitte M. Knudsen
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 611 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Imaging with ^123^I‐Ioflupane single‐photon emission computed tomography (SPECT) is a marker of nigrostriatal neuronal integrity, allowing differentiation of parkinsonism with loss of dopaminergic terminals (presynaptic Parkinson syndrome [PS]) from parkinsonism without nigrostriatal de
## Abstract Neuropsychiatric symptoms are frequent in dementia with Lewy bodies (DLB). Dopamine transporter (DAT) imaging with ^123^I‐labeled ligand __N__‐δ‐(fluoropropyl)‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)tropene (^123^I‐FP‐CIT), which reliably measures midbrain dopaminergic dysfunction, has provid